Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Immunic Inc
(NQ:
IMUX
)
1.460
+0.050 (+3.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunic Inc
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Monday's After-Market Session
October 09, 2023
Via
Benzinga
Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
August 21, 2023
--News Direct--
Via
News Direct
Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
August 21, 2023
Immunic Inc (NASDAQ:IMUX) President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive after the biotechnology company announced the completion of the enrolment of its phase 2 CALLIPER trial...
Via
TheNewswire.com
Immunic CEO says Q2 results "couldn't be better"
August 07, 2023
--News Direct--
Via
News Direct
Immunic CEO says Q2 results "couldn't be better"
August 07, 2023
Immunic Inc (NASDAQ:IMUX) president and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive following the release of the Munich-based biotechnology company's second-quarter financial results and...
Via
TheNewswire.com
Immunic Inc eyeing "big step" for multiple sclerosis patients
July 25, 2023
--News Direct--
Via
News Direct
Immunic Inc set to bring relief with encouraging results
May 16, 2023
Immunic Inc set to bring relief with encouraging results
Via
News Direct
Immunic Inc set to bring relief with encouraging results
May 16, 2023
Dr Daniel Vitt, CEO of Immunic Inc (NASDAQ:IMUX), discusses the company's encouraging first-quarter performance with Proactive.
Via
TheNewswire.com
Immunic Inc eyeing "big step" for multiple sclerosis patients
July 25, 2023
Immunic Inc (NASDAQ:IMUX) president and CEO Dr Daniel Vitt joined Thomas Warner from Proactive ahead of World Brain Day to provide an update on the biotechnology company's novel multiple sclerosis (MS)...
Via
TheNewswire.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 28, 2023
Via
Benzinga
Recap: Immunic Q1 Earnings
May 11, 2023
Via
Benzinga
Immunic IMU-856 trial data "clearly goes beyond" initial expectations
May 04, 2023
Immunic IMU-856 trial data "clearly goes beyond" initial expectations
Via
News Direct
Immunic IMU-856 trial data "clearly goes beyond" initial expectations
May 04, 2023
Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Thomas Warner from Proactive after releasing new clinical trial data for the biotechnology company's IMU-856 molecule, which is aimed at...
Via
TheNewswire.com
Why Is Immunic (IMUX) Stock Up 23% Today?
April 05, 2023
Immunic (IMUX) stock is getting a boost on Wednesday after the company released results from its Phase 2 CALDOSE-1 Trial.
Via
InvestorPlace
Preview: Immunic's Earnings
February 22, 2023
Via
Benzinga
Immunic Touts Positive Vidofludimus Calcium Data In Multiple Sclerosis Candidate
November 17, 2022
Via
Benzinga
Immunic gets a "positive surprise" from lead asset trial
April 13, 2023
Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838)...
Via
TheNewswire.com
Immunic gets a "positive surprise" from lead asset trial
April 13, 2023
Immunic gets a "positive surprise" from lead asset trial
Via
News Direct
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 05, 2023
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite...
Via
Benzinga
After Positive Data In Ulcerative Colitis Study, Immunic Prioritizes Vidofludimus Calcium Program With One More Candidate
April 05, 2023
Via
Benzinga
Why Is Nuvve (NVVE) Stock Down 14% Today?
April 05, 2023
Nuvve (NVVE) stock is down on Wednesday after the vehicle-to-grid technology company's shares underwent a rally yesterday.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 05, 2023
Via
Benzinga
Why Is Secoo (SECO) Stock Down 16% Today?
April 05, 2023
Secoo (SECO) stock is retreating on Wednesday after the Chinese products and services company saw a massive rally on Tuesday.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 05, 2023
We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders need to know about this morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
December 15, 2022
Via
Benzinga
BARK And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
November 28, 2022
The Dow Jones closed higher by more than 150 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 17, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
November 17, 2022
We're beginning the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday morning!
Via
InvestorPlace
Recap: Immunic Q3 Earnings
November 03, 2022
Immunic (NASDAQ:IMUX) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings Immunic missed estimated earnings...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.